Executive Summary
The Story So Far
Why This Matters
Who Thinks What?
Health and Human Services Secretary Robert F. Kennedy Jr. reportedly never sought briefings from scientists at the Centers for Disease Control (CDC), according to a former CDC director. This revelation follows the recent firing of CDC Director Susan Monarez on Wednesday and comes amid increasing scrutiny of public health policy under President Donald Trump’s second term.
Leadership Concerns at HHS
Demetre Daskalakis, who previously directed the CDC’s National Center for Immunization and Respiratory Diseases, stated in a CNN interview that Kennedy had not been briefed by CDC experts on critical public health issues. Daskalakis emphasized that no one from his center had briefed Secretary Kennedy on topics such as measles, COVID-19, or the flu.
Daskalakis questioned where Kennedy was obtaining his information, suggesting the Secretary might rely on “alternate experts” rather than the CDC’s scientists. Newsweek reportedly reached out to HHS for comment regarding these claims.
Background on CDC and HHS
The CDC functions as the United States’ primary public health agency, operating under the umbrella of the Health and Human Services Department. Its core mission involves safeguarding the nation’s health through various disease control and prevention initiatives. Globally recognized for its expertise, the CDC is a leading authority on infectious and chronic diseases.
The removal of Director Monarez has drawn attention to broader criticisms of public health policy within the Trump administration. Secretary Kennedy Jr.’s appointment, in particular, has faced opposition from public health experts due to his known skepticism regarding vaccines, raw milk, and water fluoridation.
Policy Shifts and Funding Cuts
Concerns surrounding Secretary Kennedy’s views have been compounded by recent departmental decisions. This month, Kennedy announced a significant cut, redirecting $500 million in federal funding from 22 mRNA vaccine development projects. He justified the decision by stating that “the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu.”
The ongoing tensions between the political leadership at HHS and the scientific community at the CDC underscore broader challenges in public health governance. The reported lack of engagement with CDC experts and the recent policy shifts continue to fuel debate among public health advocates and policymakers.